Metallo Bio

About:

Metallo Bio's focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics.

Twitter/X: biometallo

Top Investors: Innovate UK, SFC Capital, Centre for Process Innovation

Description:

Metallo Bio's focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics, with the goal of addressing the rising issue of antimicrobial resistance.

Total Funding Amount:

490000 GBP

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Sheffield, Sheffield, United Kingdom

Founded Date:

2021-03-01

Founders:

Jim Thomas, Kirsty Smitten

Number of Employees:

1-10

Last Funding Date:

2024-04-04

IPO Status:

Private

Industries: